Zhou Yilu, Liu Zhiqiang, Xu Zhendong
Department of Anesthesiology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
Department of Anesthesiology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Perioper Med (Lond). 2024 Oct 8;13(1):100. doi: 10.1186/s13741-024-00457-w.
Post-partum hemorrhage (PPH) is a leading cause of maternal death worldwide. However, the effect of blood transfusion in patients undergoing cesarean section remains unclear.
The analysis was based on the retrospective evaluation of the pre- and post-operative data for 1231 patients who underwent a cesarean section at our hospital between January 2016 and June 2020. Patients were classified into the blood transfusion group (BT) and the no blood transfusion group (NBT) based on their intra-operative blood transfusion status.
After propensity score matching, 322 patients were included in both groups and between-group differences in length of hospital stay (LOS), perioperative systemic inflammation indicators, and post-operative complications were evaluated. The LOS was longer in the BT (median, 6.6 days) than the NBT (median, 4.2 days) group (P = 0.026). The post-operative complication rate was higher for the BT than NBT group, as follows: vomiting, 3.2% vs. 4.9%, P = 0.032; fever, 5.41% vs. 2.24%, P = 0.032; wound complications, 15.44% vs. 10.45%, P = 0.028; and intestinal obstructions, 5.88% vs. 2.75%, P = 0.034. Systemic inflammation indicators increased significantly, from the pre-operative baseline, for both groups at post-operative day (POD) 1 and POD3. On multivariate analysis, intra-operative blood transfusion was associated with a longer LOS (hazard ratio, 1.52; 95% confidence interval, 1.07-2.25).
Intraoperative blood transfusion for cesarean section was associated with increased levels of systemic inflammation indicators, higher post-operative complication rates, and prolonged hospital stay.
产后出血(PPH)是全球孕产妇死亡的主要原因。然而,剖宫产患者输血的效果仍不明确。
本分析基于对2016年1月至2020年6月在我院接受剖宫产的1231例患者术前和术后数据的回顾性评估。根据术中输血情况将患者分为输血组(BT)和未输血组(NBT)。
倾向评分匹配后,两组各纳入322例患者,并评估了住院时间(LOS)、围手术期全身炎症指标和术后并发症的组间差异。BT组的LOS(中位数,6.6天)长于NBT组(中位数,4.2天)(P = 0.026)。BT组的术后并发症发生率高于NBT组,如下:呕吐,分别为3.2%和4.9%,P = 0.032;发热,分别为5.41%和2.24%,P = 0.032;伤口并发症,分别为15.44%和10.45%,P = 0.028;肠梗阻,分别为5.88%和2.75%,P = 0.034。两组术后第1天(POD)和POD3时全身炎症指标均较术前基线显著升高。多因素分析显示,术中输血与较长的LOS相关(风险比,1.52;95%置信区间,1.07 - 2.25)。
剖宫产术中输血与全身炎症指标水平升高、术后并发症发生率升高和住院时间延长有关。